Agenus maintains a global footprint by way of collaborations and partnerships with leading pharmaceutical and biotechnology providers in North America, Europe and Asia. Its agreements contain exploration and development collaborations, license arrangements and co-advancement packages targeted at accelerating the translation of novel immunotherapies